We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




UCSF Launches Artificial Intelligence Center to Advance Medical Imaging

By MedImaging International staff writers
Posted on 06 Nov 2019
Print article
Image: The Center for Intelligent Imaging is designed to, “develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease,” (Photo courtesy of UCSF).
Image: The Center for Intelligent Imaging is designed to, “develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease,” (Photo courtesy of UCSF).
The University of California San Francisco {(UCSF) San Francisco, CA, USA} has announced the launch of a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. The center aims to enable transformation via intelligent radiology, with the goal of again collaborating with the industry to become of the first institutions to bring medical imaging AI to the bedside.

UCSF investigators in ci2 will work alongside engineers and data scientists from NVIDIA Corp. (Santa Clara, CA, USA), an industry leader in AI computing, to develop clinical AI tools, applying powerful computational resources that are available in few medical institutions, with the goal of accelerating the AI development cycle and integrating it seamlessly in the clinic. Researchers in the center will use patient images and clinical data from UCSF Health and other institutions to develop, test and validate deep learning algorithms. The center’s computational infrastructure includes NVIDIA’s DGX-2 supercomputer, one of the first to be installed in the medical community. The center also will link academic innovation to startups to promote collaborative AI imaging research and development.

“Artificial intelligence represents the next frontier for diagnostic medicine. It is poised to revolutionize the way in which imaging is performed, interpreted and used to direct care for patients,” said Christopher Hess, MD, PhD, chair of the UCSF Department of Radiology and Biomedical Imaging. “The Center for Intelligent Imaging will serve as a hub for the multidisciplinary development of AI in imaging to meet unmet clinical needs and provide a platform to measure impact and outcomes of this technology. The result will be more efficient, higher-value imaging for patients within and outside of UCSF.”

“AI is one of the greatest tools of this century. ci2 is bringing together an innovative ecosystem of startups, vendors, UCSF’s thought leadership in radiology, and NVIDIA’s Clara platform on the world’s fastest GPUs, to create imaging AI solutions for improving patient care,” said Abdul Hamid Halabi, director of healthcare at NVIDIA.

Related Links:
UCSF
NVIDIA Corp.


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Thyroid Shield
Standard Thyroid Shield
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound Software
UltraExtend NX

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.